---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Natural Product Based Nanoparticles as Dietary Management and/or Treatment of Inflammatory Related Diseases"
date: 2026-02-05 19:09:32 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-09332
original_published: 2021-05-04 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Natural Product Based Nanoparticles as Dietary Management and/or Treatment of Inflammatory Related Diseases

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** May 04, 2021 00:00 UTC
**Document Number:** 2021-09332

## Summary

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to MaDu, LLC located at 2025 Broadway, Suite 23E, New York, NY 10023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/05/04/2021-09332/prospective-grant-of-an-exclusive-patent-license-natural-product-based-nanoparticles-as-dietary)
- API: https://www.federalregister.gov/api/v1/documents/2021-09332

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
